首页|骨髓基质抗原蛋白2对甲状腺乳头状癌细胞转移活性的影响

骨髓基质抗原蛋白2对甲状腺乳头状癌细胞转移活性的影响

扫码查看
目的 探究骨髓基质抗原蛋白2(BST2)调节磷脂酰肌醇3激酶/丝氨酸-苏氨酸激酶(PI3K/Akt)信号通路对甲状腺乳头状癌细胞增殖、转移和凋亡的影响。方法 选取2022年8月至2023年11月在山西省肿瘤医院诊治的11例甲状腺乳头状癌患者[(65±8)岁]中收集癌组织和癌旁组织。将甲状腺乳头状癌TPC-1细胞,通过随机数表法随机分为4组:阴性对照组,siBST2组,PI3K/Akt信号通路抑制剂组、pcDNA BST2组。免疫组化分析甲状腺乳头状癌组织和癌旁组织BST2的表达水平;CCK-8实验分析各组TPC-1细胞的增殖能力;细胞划痕实验分析各组TPC-1细胞的迁移能力;Transwell实验分析各组TPC-1细胞的侵袭能力;流式细胞术分析各组TPC-1细胞凋亡率;蛋白免疫印迹分析TPC-1细胞中BST2和PI3K/AKT通路蛋白的表达。两组间比较采用独立样本t检验。结果 甲状腺乳头状癌组织中BST2表达高于癌旁组织(0。17±0。03比0。83±0。05,t=12。905,P<0。05);siBST2组TPC-1细胞的BST、Akt、PI3K蛋白表达低于阴性对照组(0。60±0。02比0。13±0。02,t=11。367,P<0。05;0。59±0。05 比 0。11±0。03,t=9。235,P<0。05;0。51±0。06 比0。15±0。03,t=15。325,P<0。05);pcDNA BST2 组的 TPC-1 细胞的 BST、Akt、PI3K 蛋白表达高于阴性对照组(0。60±0。02 比 0。88±0。55,t=11。911,P<0。05;0。59±0。05 比 0。81±0。03,t=16。255,P<0。05;0。51±0。06 比 0。82±0。03,t=13。271,P<0。05);siBST2 组、PI3K/Akt 信号通路抑制剂组的TPC-1细胞的增殖、迁移、侵袭能力低于阴性对照组(85。12±8。12比153。28±9。88,t=12。766,P<0。05;81。62±9。33 比 153。28±9。88,t=11。698,P<0。05);siBST2 组、PI3K/Akt 信号通路抑制剂组的TPC-1细胞的凋亡率高于阴性对照组(13。05±1。16比6。70±0。12,t=9。081,P<0。05;14。36±0。98比6。70±0。12,t=11。661,P<0。05);pcDNA BST2组的TPC-1细胞的增殖、迁移、侵袭能力高于阴性对照组(209。78±15。92 比 153。28±9。88,t=12。568,P<0。05);pcDNA BST2 组的 TPC-1 细胞凋亡率低于阴性对照组(3。56±0。05比6。70±0。12,t=12。562,P<0。05)。结论 下调BST2或抑制PI3K/Akt信号通路能够抑制甲状腺乳头状癌TPC-1细胞的增殖、迁移和侵袭能力并促进TPC-1细胞凋亡。
Effect of bone marrow stromal cell antigen 2 on metastatic activity of papillary thyroid cancer cells
Objective To explore the effect of marrow stromal antigen protein 2(BST2)on prolif-eration,metastasis and apoptosis papillary thyroid cancer cells by regulating phosphatidyl inositol 3 kinase/serine and threonine kinase(PI3K/Akt)signal pathway.Methods Cancer tissues and adjacent tissues were collected from 11 patients(65±8 years old)with papillary thyroid carcinoma diagnosed and treated in Shanxi Cancer Hospital from August 2022 to November 2023.Thyroid papillary carcinoma TPC-1 cells were randomly divided into 4 groups by the random number table method:negative control group,si BST2 group,PI3K/Akt signaling pathway inhibitor group,pcDNA BST2 group.Immunohistochemistry was used to analyze the expression level of BST2 in papillary thyroid carcinoma tissues and adjacent tissues.The pro-liferation ability of TPC-1 cells in each group was analyzed by CCK-8 assay.The migration ability of TPC-1 cells in each group was analyzed by cell scratch test.Transwell assay was used to analyze the invasion ability of TPC-1 cells in each group.The apoptosis rate of TPC-1 cells in each group was analyzed by flow cytome-try.The expression of BST2 and PI3K/Akt pathway proteins in TPC-1 cells were analyzed by Western blotting.Independent sample t test was used for comparison between the two groups.Results The expres-sion of BST2 in papillary thyroid carcinoma tissues was higher than that in adjacent tissues(0.17±0.03 vs.0.83±0.05,t=12.905,P<0.05).The expression of BST,Akt,PI3K proteins in TPC-1 cells of siBST2 group was lower than in the negative control group(0.60±0.02 vs.0.13±0.02,t=11.367,P<0.05;0.59±0.05 vs.0.11±0.03,t=9.235,P<0.05;0.51±0.06 vs.0.15±0.03,t=15.325,P<0.05).The protein expression of BST,Akt and PI3K in TPC-1 cells of pcDNA BST2 group was higher than that of negative control group(0.60±0.02 vs.0.88±0.55,t=11.911,P<0.05;0.59±0.05 vs.0.81±0.03,t=16.255,P<0.05;0.51±0.06 vs.0.82±0.03,t=13.271,P<0.05).Proliferation,migration and invasion ability of TPC-1 cells in siBST2 group and PI3K/Akt signal pathway inhibitors group was lower lower than in the negative control group(85.12±8.12 vs.153.28±9.88,t=12.766,P<0.05;81.62±9.33 vs.153.28±9.88,t=11.698,P<0.05),the apoptosis rate of TPC-1 cells in the siBST2 group and the PI3K/Akt signaling pathway inhibitor group was higher than that in the negative con-trol group(13.05±1.16 vs.6.70±0.12,t=9.081,P<0.05;14.36±0.98 vs.6.70±0.12,t=11.661,P<0.05).The proliferation,migration and invasion abilities of TPC-1 cells in the pcDNA BST2 group were higher than those in the negative control group(209.78±15.92 vs.153.28±9.88,t=12.568,P<0.05).The apoptosis rate of TPC-1 cells in pcDNA BST2 groups was lower than in the nega-tive control group(3.56±0.05 vs.6.70±0.12,t=12.562,P<0.05).Conclusion Down-regulating BST2 or inhibiting PI3K/Akt signaling pathway can inhibit proliferation,migration and invasion ability of TPC-1 cells and promote apoptosis of TPC-1 cells.

Bone marrow stromal cell antigen 2Papillary thyroid carcinomaPhosphatidyl inositol 3 kinaseSerine and threonine kinaseProliferationMetastasisApoptosis

任淑惠、王山川、吴雨雷

展开 >

山西省肿瘤医院中国医学科学院肿瘤医院山西医院山西医科大学附属肿瘤医院头颈放疗科,太原 030013

山西省肿瘤医院中国医学科学院肿瘤医院山西医院山西医科大学附属肿瘤医院肿瘤内科,太原 030013

山西省肿瘤医院中国医学科学院肿瘤医院山西医院山西医科大学附属肿瘤医院头颈外科,太原 030013

骨髓基质抗原蛋白2 甲状腺乳头状癌 磷脂酰肌醇3激酶 丝氨酸-苏氨酸激酶 增殖 转移 凋亡

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(9)